Showing results (31-40 of 279) with videos related to
Sort By:
Pageof 28
Journal of Thrombosis and Thrombolysis|February 1, 2021
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancyNir Livneh, Dionne Braeken, Genady Drozdinsky, et al.Research and Practice in Thrombosis and Haemostasis|April 25, 2024
Cancer and arterial thrombosis: therapeutic optionsMay Anne Cheong, Avi LeaderHamostaseologie|April 16, 2021
Management of Disseminated Intravascular Coagulation in Acute LeukemiasHugo Ten Cate, Avi LeaderActa Haematologica|April 30, 2002
Immune-mediated complications during interferon therapy in hematological patientsPia Raanani, Isaac Ben-BassatInternational Journal of Molecular Sciences|January 8, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific MannerShirly Partouche, Idan Goldberg, Erez Halperin, et al.Annals of Medicine|March 15, 2012
Are platelet volume indices of clinical use? A multidisciplinary reviewAvi Leader, David Pereg, Michael LishnerJournal of Clinical Medicine|April 3, 2021
Challenges and Advances in Managing Thrombocytopenic Cancer PatientsAvi Leader, Liron Hofstetter, Galia SpectreLeukemia & Lymphoma|May 26, 2020
Changes in primary outcome and sample size measures after initiation of accrual among trials supporting approval of drugs for hematological malignancies by the US food and drug administrationIrina Amitai, Pia Raanani, Daniel ShepshelovichThrombosis and Haemostasis|January 1, 2019
Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based ExperimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.Journal of Thrombosis and Thrombolysis|September 27, 2018
Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndromeRoy Ratzon, Shlomit Tamir, Tal Friehmann, et al.Pageof 28